Our specialists look at each inquiry to make sure it reaches the right experts.
If your request is a fit, a team member will get in touch to provide further information or clarify any details
HMOs are the third largest component of breastmilk (excluding water) after fat and lactose, suggesting this bioactive component could play a significant role in infant development and overall human health. In this first of a 3-part series, we explore the evolving science around how HMOs might influence the gut-brain-immune axis.
Discover key insights from FCE Pharma on the latest pharmaceutical trends and technologies innovating the LATAM market.
Discover the top 5 trends transforming pharma regulations in Asia-Pacific and how drug developers can navigate this evolving landscape with dsm-firmenich.
Discover how we bring progress to life through purpose-led science, sustainable solutions, building on our 150-year heritage and leading by example.
We're here to bring progress to life. The secret? Combining the essential, the desirable, and the sustainable.
We believe in doing business the right way. And our policies and procedures support this ambition at every turn.